NCT04089254 Suicide Treatment Alternatives for Teens
| NCT ID | NCT04089254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | Suicidal Ideation |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-11-04 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2019-11-04 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Quasi-Randomized trial to compare inpatient care versus outpatient crisis intervention clinic. This study plans to enroll up to 1,000 participants across 4 sites in a 5 years period.
Eligibility Criteria
Inclusion Criteria: 1. Adolescents that are 12 through 17 years old (including 17 year olds who will turn 18 years old during the course of the study). 2. Are brought to the Emergency Department (ED) due to suicidal thoughts or behaviors 3. Require a higher level of care (OCIC or Inpatient) indicated by clinician determination and a CHRT-SR score of 15 to 52. 4. The presence of a legal guardian 5. Capable of giving signed informed consent/assent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol. Exclusion Criteria: 1. Adolescents with suicidal thoughts that place themselves at a serious imminent risk of suicide based on clinical judgment. 2. Adolescents who require 24 hour/day supervision but no adult can provide 24 hour/day supervision outside of the hospital 3. Adolescents without the ability to read and answer survey questions 4. Adolescents that are non-English speaking due to the scales and surveys that are used for this study only being available in English.
Contact & Investigator
Drew Barzman, MD
PRINCIPAL INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT04089254 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Suicidal Ideation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04089254 currently recruiting?
Yes, NCT04089254 is actively recruiting participants. Contact the research team at drew.barzman@cchmc.org for enrollment information.
Where is the NCT04089254 trial being conducted?
This trial is being conducted at Glen Oaks, United States, Cincinnati, United States, Columbus, United States, Dallas, United States.
Who is sponsoring the NCT04089254 clinical trial?
NCT04089254 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Drew Barzman, MD at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 1,000 participants.